Andrew Cooper Stock Analyst Profile - Raymond James Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Andrew Cooper

    Stock Analyst at Raymond James

    (3.85)
    # 2144
    Out of 5,459 analysts
    174
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Basic Materials
    Top Industries:
    Medical - Diagnostics & Research Medical - Instruments & Supplies Chemicals - Specialty
    26 Stocks
    Name Action PT Current % Upside Ratings Updated
    HAE Haemonetics
    Downgrades: Outperform
    105 78
    		55.05 41.69% 10 Aug 11, 2025
    AZTA Azenta
    Upgrades: Outperform
    35
    		30.2 15.89% 2 Aug 6, 2025
    AVTR Avantor
    Reiterates: Outperform
    16 14
    		13.2 6.06% 15 Aug 4, 2025
    GH Guardant Health
    Maintains: Outperform
    59 61
    		63.5 -3.94% 4 Jul 31, 2025
    RVTY Revvity
    Reiterates: Outperform
    120 115
    		88.55 29.87% 9 Jul 29, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    150 143
    		108.17 32.2% 3 Jul 25, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    525 535
    		488.13 9.6% 7 Jul 24, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    19 10
    		5.93 68.63% 5 May 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    24 25
    		21.64 15.53% 2 May 5, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Outperform
    90 71
    		66.73 6.4% 12 May 2, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Market Perform
    n/a
    		n/a n/a 1 Mar 28, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 8 Feb 3, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Market Perform
    n/a
    		n/a n/a 8 Sep 26, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 16 May 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Outperform
    68 85
    		163.04 -47.87% 5 Feb 20, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Outperform
    100 76
    		27.77 173.68% 12 Feb 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    1 1
    		n/a n/a 10 Aug 28, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Market Perform
    n/a
    		n/a n/a 1 Jul 19, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 14 May 16, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Underperform
    n/a
    		n/a n/a 7 May 15, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 8 Jan 18, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 5 Sep 22, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Market Perform
    n/a
    		n/a n/a 4 Jun 3, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    31 39
    		20.99 85.8% 1 Mar 2, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    145 225
    		119.99 87.52% 4 Feb 24, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Strong Buy
    20
    		n/a n/a 1 Mar 18, 2020